Reported a net loss of $19.4 million for the three months ended March 31, 2026, compared to $2.1 million in the same period of 2025. Revenue for the quarter was $20,000, down slightly from $23,000 in Q1 2025. Operating expenses decreased to $2.6 million from $3.4 million in the prior year period, primarily due to lower R&D and G&A costs. Non-operating expenses totaled $16.8 million, largely driven by an $11.9 million loss on the execution of an equity line of credit (ELOC) and $3.8 million in debt extinguishment costs. Cash and cash equivalents increased to $7.6 million as of March 31, 2026, from $0.4 million at year-end 2025, following multiple financing transactions. Management acknowledges substantial doubt regarding the company's ability to continue as a going concern.